{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:42:04Z","timestamp":1790653324082,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T00:00:00Z","timestamp":1320364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s11695-011-0545-4","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T06:13:40Z","timestamp":1320300820000},"page":"62-69","source":"Crossref","is-referenced-by-count":59,"title":["Prevalence of Endocrine Disorders in Morbidly Obese Patients and the Effects of Bariatric Surgery on Endocrine and Metabolic Parameters"],"prefix":"10.1007","volume":"22","author":[{"given":"Dra\u017eenka","family":"Jankovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-Heinz","family":"Anderwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Winhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Promintzer-Schifferl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ludvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Gessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,4]]},"reference":[{"key":"545_CR1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0889-8529(03)00078-1","volume":"32","author":"P Kokkoris","year":"2003","unstructured":"Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am. 2003;32:895\u2013914.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"545_CR2","first-page":"214","volume":"44","author":"GL Maddox","year":"1969","unstructured":"Maddox GL, Liederman V. Overweight as a social disability with medical implications. J Med Educ. 1969;44:214\u201320.","journal-title":"J Med Educ"},{"key":"545_CR3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0749-3797(18)31234-0","volume":"3","author":"JH Price","year":"1987","unstructured":"Price JH, Desmond SM, Krol RA, et al. Family practice physicians\u2019 beliefs, attitudes, and practices regarding obesity. Am J Prev Med. 1987;3:339\u201345.","journal-title":"Am J Prev Med"},{"key":"545_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/thy.2006.16.73","volume":"16","author":"MA Michalaki","year":"2006","unstructured":"Michalaki MA, Vagenakis AG, Leonardou AS, et al. Thyroid function in humans with morbid obesity. Thyroid. 2006;16:73\u20138.","journal-title":"Thyroid"},{"key":"545_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2265.2003.01836.x","volume":"59","author":"R Sari","year":"2003","unstructured":"Sari R, Balci MK, Altunbas H, et al. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol (Oxf). 2003;59:258\u201362.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"545_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1381\/096089204323013514","volume":"14","author":"Y Raftopoulos","year":"2004","unstructured":"Raftopoulos Y, Gagne DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14:509\u201313.","journal-title":"Obes Surg"},{"key":"545_CR7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11695-007-9279-8","volume":"18","author":"R Fazylov","year":"2008","unstructured":"Fazylov R, Soto E, Cohen S, et al. Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism. Obes Surg. 2008;18:644\u20137.","journal-title":"Obes Surg"},{"key":"545_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03324997","volume":"8","author":"S Alagna","year":"2003","unstructured":"Alagna S, Cossu ML, Masala A, et al. Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery. Eat Weight Disord. 2003;8:95\u20139.","journal-title":"Eat Weight Disord"},{"key":"545_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF03350300","volume":"20","author":"S Buscemi","year":"1997","unstructured":"Buscemi S, Verga S, Maneri R, et al. Influences of obesity and weight loss on thyroid hormones. A 3\u20133.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass. J Endocrinol Invest. 1997;20:276\u201381.","journal-title":"J Endocrinol Invest"},{"key":"545_CR10","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","volume":"88","author":"B Catargi","year":"2003","unstructured":"Catargi B, Rigalleau V, Poussin A, et al. Occult Cushing\u2019s syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003;88:5808\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193\u2013202.","journal-title":"Hypertens Res"},{"key":"545_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson Jr","year":"1994","unstructured":"Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609\u201315.","journal-title":"J Hypertens"},{"key":"545_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S1807-59322010000100003","volume":"65","author":"O Tiryakioglu","year":"2010","unstructured":"Tiryakioglu O, Ugurlu S, Yalin S, et al. Screening for Cushing\u2019s syndrome in obese patients. Clinics (Sao Paulo). 2010;65:9\u201313.","journal-title":"Clinics (Sao Paulo)"},{"key":"545_CR14","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2337\/dc07-0422","volume":"30","author":"C Anderwald","year":"2007","unstructured":"Anderwald C, Anderwald-Stadler M, Promintzer M, et al. The Clamp-like index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care. 2007;30:2374\u201380.","journal-title":"Diabetes Care"},{"key":"545_CR15","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2006-2522","volume":"92","author":"M Promintzer","year":"2007","unstructured":"Promintzer M, Krebs M, Todoric J, et al. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab. 2007;92:4306\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR16","doi-asserted-by":"crossref","unstructured":"Chiodini I. Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011.","DOI":"10.1210\/jc.2010-2722"},{"key":"545_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1210910","volume":"94","author":"T Nickelsen","year":"1989","unstructured":"Nickelsen T, Lissner W, Schoffling K. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol. 1989;94:275\u201380.","journal-title":"Exp Clin Endocrinol"},{"key":"545_CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2007.02784.x","volume":"66","author":"AC Qureshi","year":"2007","unstructured":"Qureshi AC, Bahri A, Breen LA, et al. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol (Oxf). 2007;66:632\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"545_CR19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR20","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u2013421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"545_CR21","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1210\/jc.2008-2766","volume":"94","author":"SK Baid","year":"2009","unstructured":"Baid SK, Rubino D, Sinaii N, et al. Specificity of screening tests for Cushing\u2019s syndrome in an overweight and obese population. J Clin Endocrinol Metab. 2009;94:3857\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM200107263450406","volume":"345","author":"DS Cooper","year":"2001","unstructured":"Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001;345:260\u20135.","journal-title":"N Engl J Med"},{"key":"545_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0889-8529(01)00023-8","volume":"31","author":"L Douyon","year":"2002","unstructured":"Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am. 2002;31:173\u201389.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"545_CR24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/jc.82.4.1118","volume":"82","author":"H al-Adsani","year":"1997","unstructured":"al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab. 1997;82:1118\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-2007-978672","volume":"32","author":"A Sorisky","year":"2000","unstructured":"Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horm Metab Res. 2000;32:468\u201374.","journal-title":"Horm Metab Res"},{"key":"545_CR26","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1210\/jc.87.5.2352","volume":"87","author":"RW Valyasevi","year":"2002","unstructured":"Valyasevi RW, Harteneck DA, Dutton CM, et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab. 2002;87:2352\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR27","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1210\/en.2003-1312","volume":"145","author":"F Guo","year":"2004","unstructured":"Guo F, Bakal K, Minokoshi Y, et al. Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology. 2004;145:2221\u20137.","journal-title":"Endocrinology"},{"key":"545_CR28","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2005-0920","volume":"90","author":"P Kok","year":"2005","unstructured":"Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 2005;90:4659\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1381\/096089205774512537","volume":"15","author":"Moulin Moraes CM de","year":"2005","unstructured":"de Moraes CM Moulin, Mancini MC, de Melo ME, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg. 2005;15:1287\u201391.","journal-title":"Obes Surg"},{"key":"545_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mce.2009.06.005","volume":"316","author":"T Reinehr","year":"2010","unstructured":"Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316:165\u201371.","journal-title":"Mol Cell Endocrinol"},{"key":"545_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.84.3.1022","volume":"84","author":"PM Stewart","year":"1999","unstructured":"Stewart PM, Boulton A, Kumar S, et al. Cortisol metabolism in human obesity: impaired cortisone\u2013 > cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab. 1999;84:1022\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.1997.tb00002.x","volume":"241","author":"A Hautanen","year":"1997","unstructured":"Hautanen A, Raikkonen K, Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males. J Intern Med. 1997;241:451\u201361.","journal-title":"J Intern Med"},{"key":"545_CR33","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2337\/dc06-1353","volume":"30","author":"M Manco","year":"2007","unstructured":"Manco M, Fernandez-Real JM, Valera-Mora ME, et al. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care. 2007;30:1494\u2013500.","journal-title":"Diabetes Care"},{"key":"545_CR34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","volume":"99","author":"C Lambillotte","year":"1997","unstructured":"Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997;99:414\u201323.","journal-title":"J Clin Invest"},{"key":"545_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/eje.1.02228","volume":"155","author":"B Mariniello","year":"2006","unstructured":"Mariniello B, Ronconi V, Rilli S, et al. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing\u2019s syndrome. Eur J Endocrinol. 2006;155:435\u201341.","journal-title":"Eur J Endocrinol"},{"key":"545_CR36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/oby.2006.92","volume":"14","author":"R Desbriere","year":"2006","unstructured":"Desbriere R, Vuaroqueaux V, Achard V, et al. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring). 2006;14:794\u20138.","journal-title":"Obesity (Silver Spring)"},{"key":"545_CR37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/jc.83.4.1325","volume":"83","author":"ML Ricketts","year":"1998","unstructured":"Ricketts ML, Verhaeg JM, Bujalska I, et al. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998;83:1325\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR38","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2005-01-0186","volume":"106","author":"L Freeman","year":"2005","unstructured":"Freeman L, Hewison M, Hughes SV, et al. Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood. 2005;106:2042\u20139.","journal-title":"Blood"},{"key":"545_CR39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s11695-008-9616-6","volume":"19","author":"R Munoz","year":"2009","unstructured":"Munoz R, Carvajal C, Escalona A, et al. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients. Obes Surg. 2009;19:764\u201370.","journal-title":"Obes Surg"},{"key":"545_CR40","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","volume":"94","author":"P Anagnostis","year":"2009","unstructured":"Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692\u2013701.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2265.2003.01750.x","volume":"58","author":"AM Ward","year":"2003","unstructured":"Ward AM, Fall CH, Stein CE, et al. Cortisol and the metabolic syndrome in South Asians. Clin Endocrinol (Oxf). 2003;58:500\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"545_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0277-9536(95)00333-9","volume":"43","author":"N Ravaja","year":"1996","unstructured":"Ravaja N, Keltikangas-Jarvinen L, Viikari J. Life changes, locus of control and metabolic syndrome precursors in adolescents and young adults: a three-year follow-up. Soc Sci Med. 1996;43:51\u201361.","journal-title":"Soc Sci Med"},{"key":"545_CR43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1262-3636(07)70156-8","volume":"30","author":"AD Karelis","year":"2004","unstructured":"Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30:569\u201372.","journal-title":"Diabetes Metab"},{"key":"545_CR44","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/jc.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR45","doi-asserted-by":"crossref","unstructured":"Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2010.","DOI":"10.1038\/ijo.2010.216"},{"key":"545_CR46","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","volume":"47","author":"E Bonora","year":"1998","unstructured":"Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643\u20139.","journal-title":"Diabetes"},{"key":"545_CR47","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","volume":"100","author":"E Ferrannini","year":"1997","unstructured":"Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997;100:1166\u201373.","journal-title":"J Clin Invest"},{"key":"545_CR48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","volume":"168","author":"RP Wildman","year":"2008","unstructured":"Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004). Arch Intern Med. 2008;168:1617\u201324.","journal-title":"Arch Intern Med"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-011-0545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-011-0545-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-011-0545-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T01:10:08Z","timestamp":1560906608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-011-0545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1007\/s11695-011-0545-4","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,4]]}}}